The Spanish Association of Orphan and Ultra-Orphan Drug Laboratories (AELMHU) and the General Council of Pharmaceutical Associations (CGCOF) have signed a collaboration agreement to promote the skills of pharmacists in this type of drugs for the prevention, diagnosis or treatment of rare diseases.

The president of the General Council of Pharmaceutical Associations, Jesús Aguilar, and the president of AELMHU, Beatriz Perales, have signed the document that includes the joint organization of training or informative activities, as well as health programs and campaigns. The first action to be promoted by both entities is the launch of the "Pharmacy and Orphan Drugs" channel, within the video advice channel #TuFarmacéuticoInforma that the General Council of Pharmaceutical Associations has on YouTube.

Access the complete note here